48/100
Opportunity
Commercial fit6/25
Clinical timing20/20
Biomarker need5/20
Relationship2/10
Signal strength9/10
Account value5/10
Urgency1/5
New phase 1 trial NCT06956261 posted by Peking University: "NW-301 TCR-T in Patients With Advanced Solid Tumor". New trial on a phase 1 not yet recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).
Why nowClinicalTrials.gov record updated 492 days ago.
ConfidenceHigh · 87%